UCD Clinical Trials
Dr O’Gorman runs a busy clinical trials program at the UCD Catherine McCauley Clinical Trails Centre, Mater University Hospital.
In his capacity as National Haematology Modality Clinical Trials Co-ordinator with the Irish Cooperative Clinical Oncology Group (www.icorg.ie) he is actively promoting trials of novel therapeutic strategies for Blood Cancers.
Dr Peter O’Gorman is Chair of the National Hematology Clinical Trials Program with the Irish Clinical Oncology Research Program 2011-2016. Www.icorg.ie “While we have made great progress in recent years leading to much improved survival in patients with blood cancer we cannot get complacent. My goal is to establish Ireland as a key contributor to the international effort to cure blood cancers with new therapies. By participating in international clinical trials of emerging new drugs we ensure our patients have real-time access to the treatments they need”.
“We are making significant progress in the battle against Blood Cancers. Through MIRT’s international links I have secured a number of trials of novel drugs. My goal as Chair of the National Hematology Trials Program is twofold: 1. to promote Ireland as a key player in international blood cancer translational research and 2. to facilitate early access for patients with blood cancer to the best new drugs” says Dr. O’Gorman.
Through our link with the Dana Farber Cancer Institute, Harvard University, we are in a unique position to provide the Irish arm of their international trials of new Blood Cancer treatments. In addition we provide the proteomics analysis for samples taken from participating trial patients at the NICB, DCU.
More information about the UCD school of medicine can be found here